Taken together, these results suggest that CBN suppresses the cellular proliferation, invasion, and angiogenesis of neuroblastoma via inhibiting the AKT pathway and enhancing tumor suppressor miR-34a expression. This evidence concerns the gene AKT1 and neuroblastoma.